Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as

HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology company focusing on...

Related Keywords

China ,Delian ,Fujian ,Hangzhou ,Zhejiang ,Guobao Zhao ,Donghao Chen ,Hangzhou Chance Pharmaceuticals Co ,Hangzhou Chance Pharmaceuticals ,Chance Pharmaceuticals ,Nasdaq ,Senior Vice President ,Delian Capital ,Hummingbird Bioscience ,Senior Vice ,Hangzhou Chance Pharma ,